

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.72650700 |
| 2 | sarcomere organization (GO:0045214) | 9.49099994 |
| 3 | myofibril assembly (GO:0030239) | 8.43871869 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.10613850 |
| 5 | * muscle filament sliding (GO:0030049) | 7.56030321 |
| 6 | * actin-myosin filament sliding (GO:0033275) | 7.56030321 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.35624950 |
| 8 | * cardiac muscle contraction (GO:0060048) | 7.08228647 |
| 9 | cardiac muscle cell development (GO:0055013) | 7.03912174 |
| 10 | skeletal muscle contraction (GO:0003009) | 6.63760758 |
| 11 | cardiac cell development (GO:0055006) | 6.62178862 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 6.58425275 |
| 13 | * cardiac muscle tissue morphogenesis (GO:0055008) | 6.40254153 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.38843059 |
| 15 | cardiac muscle hypertrophy (GO:0003300) | 6.28071780 |
| 16 | * actin-mediated cell contraction (GO:0070252) | 6.27787579 |
| 17 | adult heart development (GO:0007512) | 6.27474335 |
| 18 | regulation of relaxation of muscle (GO:1901077) | 6.25217949 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 6.23375125 |
| 20 | actomyosin structure organization (GO:0031032) | 6.18550154 |
| 21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.16759167 |
| 22 | * ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.11482737 |
| 23 | heart process (GO:0003015) | 6.08994827 |
| 24 | heart contraction (GO:0060047) | 6.08994827 |
| 25 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.02392747 |
| 26 | striated muscle hypertrophy (GO:0014897) | 5.93700344 |
| 27 | regulation of sarcomere organization (GO:0060297) | 5.92554631 |
| 28 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.83859122 |
| 29 | heart trabecula formation (GO:0060347) | 5.71258943 |
| 30 | * muscle tissue morphogenesis (GO:0060415) | 5.70866455 |
| 31 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.68873486 |
| 32 | plasma membrane repair (GO:0001778) | 5.63859699 |
| 33 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.60906260 |
| 34 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.56883318 |
| 35 | creatine metabolic process (GO:0006600) | 5.49661129 |
| 36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.45342710 |
| 37 | * striated muscle contraction (GO:0006941) | 5.43363821 |
| 38 | regulation of skeletal muscle contraction (GO:0014819) | 5.30965756 |
| 39 | muscle hypertrophy (GO:0014896) | 5.27433316 |
| 40 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.11384180 |
| 41 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.10664456 |
| 42 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.09474420 |
| 43 | ATP synthesis coupled proton transport (GO:0015986) | 5.09474420 |
| 44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.83214651 |
| 45 | * regulation of striated muscle contraction (GO:0006942) | 4.79085418 |
| 46 | * regulation of the force of heart contraction (GO:0002026) | 4.76124394 |
| 47 | carnitine shuttle (GO:0006853) | 4.75940125 |
| 48 | regulation of membrane repolarization (GO:0060306) | 4.70356241 |
| 49 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.66600371 |
| 50 | * actin filament-based movement (GO:0030048) | 4.64865036 |
| 51 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.63786985 |
| 52 | regulation of cardioblast differentiation (GO:0051890) | 4.63073821 |
| 53 | response to muscle activity (GO:0014850) | 4.63017714 |
| 54 | regulation of cell communication by electrical coupling (GO:0010649) | 4.62630027 |
| 55 | oxidative phosphorylation (GO:0006119) | 4.59193283 |
| 56 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.57491887 |
| 57 | cell communication involved in cardiac conduction (GO:0086065) | 4.56368565 |
| 58 | * muscle system process (GO:0003012) | 4.53266430 |
| 59 | respiratory electron transport chain (GO:0022904) | 4.49650794 |
| 60 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.45021906 |
| 61 | muscle hypertrophy in response to stress (GO:0003299) | 4.45021906 |
| 62 | cardiac muscle adaptation (GO:0014887) | 4.45021906 |
| 63 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.44693983 |
| 64 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.42893288 |
| 65 | ventricular cardiac muscle cell development (GO:0055015) | 4.41099075 |
| 66 | electron transport chain (GO:0022900) | 4.37065815 |
| 67 | regulation of coenzyme metabolic process (GO:0051196) | 4.28776713 |
| 68 | regulation of cofactor metabolic process (GO:0051193) | 4.28776713 |
| 69 | negative regulation of protein localization to cell surface (GO:2000009) | 4.24704240 |
| 70 | regulation of heart rate (GO:0002027) | 4.16348442 |
| 71 | cell communication by electrical coupling (GO:0010644) | 4.14302930 |
| 72 | regulation of cardiac muscle contraction (GO:0055117) | 4.14108641 |
| 73 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.12081761 |
| 74 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.09885487 |
| 75 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.09471432 |
| 76 | fatty acid transmembrane transport (GO:1902001) | 4.08135027 |
| 77 | cardiac muscle cell action potential (GO:0086001) | 4.05284619 |
| 78 | cardiac ventricle formation (GO:0003211) | 4.02099838 |
| 79 | negative regulation of potassium ion transport (GO:0043267) | 3.97629240 |
| 80 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.96916094 |
| 81 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.96916094 |
| 82 | relaxation of cardiac muscle (GO:0055119) | 3.88098531 |
| 83 | striated muscle cell development (GO:0055002) | 3.87468912 |
| 84 | skeletal muscle adaptation (GO:0043501) | 3.86672750 |
| 85 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.80992614 |
| 86 | * regulation of ATPase activity (GO:0043462) | 3.75416735 |
| 87 | * regulation of ATP catabolic process (GO:1903289) | 3.75416735 |
| 88 | NADH metabolic process (GO:0006734) | 3.73959081 |
| 89 | muscle fiber development (GO:0048747) | 3.73302939 |
| 90 | * regulation of heart contraction (GO:0008016) | 3.70187725 |
| 91 | trabecula formation (GO:0060343) | 3.68289889 |
| 92 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.67672731 |
| 93 | cardiac conduction (GO:0061337) | 3.63234544 |
| 94 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.56541594 |
| 95 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.56280079 |
| 96 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.56280079 |
| 97 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.53073747 |
| 98 | detection of calcium ion (GO:0005513) | 3.49961071 |
| 99 | positive regulation of cation channel activity (GO:2001259) | 3.48793284 |
| 100 | carnitine transmembrane transport (GO:1902603) | 3.47454911 |
| 101 | 2-oxoglutarate metabolic process (GO:0006103) | 3.46115475 |
| 102 | * regulation of muscle system process (GO:0090257) | 3.45350030 |
| 103 | relaxation of muscle (GO:0090075) | 3.43625567 |
| 104 | regulation of sulfur metabolic process (GO:0042762) | 3.43258691 |
| 105 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.42114865 |
| 106 | response to caffeine (GO:0031000) | 3.41596259 |
| 107 | regulation of sequestering of triglyceride (GO:0010889) | 3.40250180 |
| 108 | cardiac chamber formation (GO:0003207) | 3.39575255 |
| 109 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.39363786 |
| 110 | positive regulation of heart rate (GO:0010460) | 3.39339640 |
| 111 | * muscle contraction (GO:0006936) | 3.38590635 |
| 112 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.37082653 |
| 113 | ATP biosynthetic process (GO:0006754) | 3.36813909 |
| 114 | positive regulation of heart contraction (GO:0045823) | 3.35187938 |
| 115 | response to epinephrine (GO:0071871) | 3.34907250 |
| 116 | * regulation of muscle contraction (GO:0006937) | 3.34861598 |
| 117 | muscle adaptation (GO:0043500) | 3.34255355 |
| 118 | muscle cell development (GO:0055001) | 3.32688776 |
| 119 | striated muscle adaptation (GO:0014888) | 3.30301241 |
| 120 | response to inactivity (GO:0014854) | 3.29192515 |
| 121 | skeletal muscle fiber development (GO:0048741) | 3.26440456 |
| 122 | cellular response to epinephrine stimulus (GO:0071872) | 3.26164181 |
| 123 | glycogen catabolic process (GO:0005980) | 3.24688631 |
| 124 | potassium ion export (GO:0071435) | 3.24673103 |
| 125 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.23384479 |
| 126 | glycogen biosynthetic process (GO:0005978) | 3.16976125 |
| 127 | glucan biosynthetic process (GO:0009250) | 3.16976125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.36635111 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 6.12132462 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.43524773 |
| 4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.51362621 |
| 5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.51362621 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.07450926 |
| 7 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.92201081 |
| 8 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.52901196 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.50300438 |
| 10 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 3.13908082 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.83481595 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72655270 |
| 13 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.63425454 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.62657690 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.61109862 |
| 16 | * RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.40334772 |
| 17 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.28186190 |
| 18 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.07511373 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02313700 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.91555956 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.84889092 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.83592244 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.82035154 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81704933 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72091595 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69054050 |
| 27 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.68367602 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67143460 |
| 29 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.59984930 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59576051 |
| 31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.48708831 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47607762 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41705084 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.40187493 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38846717 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.37144269 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32125581 |
| 38 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.30879144 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29155427 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24942667 |
| 41 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24412082 |
| 42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24047022 |
| 43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.20196063 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16548797 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13092132 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11946478 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11080304 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.11028711 |
| 49 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.10957983 |
| 50 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10636706 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10469316 |
| 52 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.08118516 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08109120 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07790831 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05949206 |
| 56 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05772962 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05331681 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05327398 |
| 59 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04537188 |
| 60 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03682686 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03093121 |
| 62 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02776490 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99476870 |
| 64 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98916127 |
| 65 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98916127 |
| 66 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98861488 |
| 67 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.98309623 |
| 68 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.97286635 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96223343 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95255602 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94266220 |
| 72 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93942045 |
| 73 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92761681 |
| 74 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.92447726 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91173922 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.91054918 |
| 77 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.90643264 |
| 78 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.90380330 |
| 79 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89019620 |
| 80 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88308870 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87607531 |
| 82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87442305 |
| 83 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.86461282 |
| 84 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.86146011 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86045644 |
| 86 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.86040746 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85865896 |
| 88 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85656372 |
| 89 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.85627751 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85578226 |
| 91 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85422216 |
| 92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84849606 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.83986721 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83880677 |
| 95 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.81528708 |
| 96 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80878433 |
| 97 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.80666621 |
| 98 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.80655249 |
| 99 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80347954 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80184657 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79885271 |
| 102 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.79825506 |
| 103 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.79802301 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79481085 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79481085 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79457923 |
| 107 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78927055 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78680394 |
| 109 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.76763690 |
| 110 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.76644703 |
| 111 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.76326761 |
| 112 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76274959 |
| 113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76197459 |
| 114 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.76128828 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.74617151 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74610277 |
| 117 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74231447 |
| 118 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73834465 |
| 119 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.73746903 |
| 120 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.73559753 |
| 121 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73325968 |
| 122 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.72179170 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71953687 |
| 124 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.71943635 |
| 125 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71470068 |
| 126 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.71379413 |
| 127 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.70909862 |
| 128 | P68_20966046_ChIP-Seq_HELA_Human | 0.70837661 |
| 129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.70747375 |
| 130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69920557 |
| 131 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69592281 |
| 132 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.69255719 |
| 133 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.68991470 |
| 134 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.68889254 |
| 135 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.68771350 |
| 136 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.68552160 |
| 137 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.68223468 |
| 138 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.67847738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.57450047 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.44305110 |
| 3 | MP0003646_muscle_fatigue | 5.14189676 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.84960774 |
| 5 | MP0000751_myopathy | 4.80381484 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.55972226 |
| 7 | MP0005330_cardiomyopathy | 4.15373735 |
| 8 | MP0000749_muscle_degeneration | 4.11031662 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.49073978 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.23314209 |
| 11 | MP0004087_abnormal_muscle_fiber | 3.12387741 |
| 12 | MP0003137_abnormal_impulse_conducting | 3.05389879 |
| 13 | MP0010630_abnormal_cardiac_muscle | 2.82812977 |
| 14 | MP0001544_abnormal_cardiovascular_syste | 2.80140201 |
| 15 | MP0005385_cardiovascular_system_phenoty | 2.80140201 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.79675129 |
| 17 | MP0006138_congestive_heart_failure | 2.67655689 |
| 18 | MP0003828_pulmonary_edema | 2.59336277 |
| 19 | MP0004484_altered_response_of | 2.49963652 |
| 20 | MP0000750_abnormal_muscle_regeneration | 2.48161391 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.41650320 |
| 22 | MP0004085_abnormal_heartbeat | 2.33211267 |
| 23 | MP0003221_abnormal_cardiomyocyte_apopto | 2.23011799 |
| 24 | MP0002269_muscular_atrophy | 2.21937151 |
| 25 | MP0004510_myositis | 2.14618454 |
| 26 | MP0004130_abnormal_muscle_cell | 2.11285717 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 2.05231905 |
| 28 | MP0002127_abnormal_cardiovascular_syste | 1.94493953 |
| 29 | MP0005369_muscle_phenotype | 1.93627914 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.81788403 |
| 31 | MP0000759_abnormal_skeletal_muscle | 1.79658620 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.78637790 |
| 33 | MP0000747_muscle_weakness | 1.76842948 |
| 34 | MP0004233_abnormal_muscle_weight | 1.62494482 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.61697110 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.36376316 |
| 37 | MP0000266_abnormal_heart_morphology | 1.25052469 |
| 38 | MP0003279_aneurysm | 1.15466227 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.12812988 |
| 40 | MP0005451_abnormal_body_composition | 1.12796275 |
| 41 | MP0000343_altered_response_to | 1.12165847 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.12111360 |
| 43 | MP0002234_abnormal_pharynx_morphology | 1.07219621 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.06349771 |
| 45 | MP0005670_abnormal_white_adipose | 1.02228181 |
| 46 | MP0005165_increased_susceptibility_to | 1.01486387 |
| 47 | MP0001661_extended_life_span | 0.94534924 |
| 48 | MP0002128_abnormal_blood_circulation | 0.84778196 |
| 49 | MP0000230_abnormal_systemic_arterial | 0.84580585 |
| 50 | MP0003566_abnormal_cell_adhesion | 0.82794065 |
| 51 | MP0005266_abnormal_metabolism | 0.80240474 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 0.76906593 |
| 53 | MP0004272_abnormal_basement_membrane | 0.73048583 |
| 54 | MP0005375_adipose_tissue_phenotype | 0.71851538 |
| 55 | MP0005623_abnormal_meninges_morphology | 0.68152984 |
| 56 | MP0000767_abnormal_smooth_muscle | 0.66783652 |
| 57 | MP0002108_abnormal_muscle_morphology | 0.66048715 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 0.63546307 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 0.63290867 |
| 60 | MP0003984_embryonic_growth_retardation | 0.58444545 |
| 61 | MP0002088_abnormal_embryonic_growth/wei | 0.57943477 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 0.57609171 |
| 63 | MP0002925_abnormal_cardiovascular_devel | 0.56633110 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 0.55238107 |
| 65 | MP0003045_fibrosis | 0.54841080 |
| 66 | MP0009384_cardiac_valve_regurgitation | 0.54349323 |
| 67 | MP0004270_analgesia | 0.48897856 |
| 68 | MP0002909_abnormal_adrenal_gland | 0.46881026 |
| 69 | MP0000733_abnormal_muscle_development | 0.46794276 |
| 70 | MP0008569_lethality_at_weaning | 0.45778589 |
| 71 | MP0004043_abnormal_pH_regulation | 0.45659821 |
| 72 | MP0001784_abnormal_fluid_regulation | 0.44633444 |
| 73 | MP0001614_abnormal_blood_vessel | 0.42522119 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 0.42003815 |
| 75 | MP0005187_abnormal_penis_morphology | 0.40924270 |
| 76 | MP0008438_abnormal_cutaneous_collagen | 0.40008906 |
| 77 | MP0003122_maternal_imprinting | 0.39785999 |
| 78 | MP0004147_increased_porphyrin_level | 0.39355873 |
| 79 | MP0000003_abnormal_adipose_tissue | 0.38807915 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.37963437 |
| 81 | MP0001299_abnormal_eye_distance/ | 0.37916596 |
| 82 | MP0000013_abnormal_adipose_tissue | 0.37418434 |
| 83 | MP0002822_catalepsy | 0.36218838 |
| 84 | MP0001672_abnormal_embryogenesis/_devel | 0.35221811 |
| 85 | MP0005380_embryogenesis_phenotype | 0.35221811 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 0.33362425 |
| 87 | MP0003948_abnormal_gas_homeostasis | 0.32921566 |
| 88 | MP0005595_abnormal_vascular_smooth | 0.32621300 |
| 89 | MP0003878_abnormal_ear_physiology | 0.31992735 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.31992735 |
| 91 | MP0002971_abnormal_brown_adipose | 0.30518384 |
| 92 | MP0001727_abnormal_embryo_implantation | 0.29121599 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.26589560 |
| 94 | MP0005388_respiratory_system_phenotype | 0.26103702 |
| 95 | MP0002133_abnormal_respiratory_system | 0.26103702 |
| 96 | MP0005334_abnormal_fat_pad | 0.25285613 |
| 97 | MP0000762_abnormal_tongue_morphology | 0.24960874 |
| 98 | MP0005275_abnormal_skin_tensile | 0.24635252 |
| 99 | MP0003941_abnormal_skin_development | 0.22056398 |
| 100 | MP0005386_behavior/neurological_phenoty | 0.21790609 |
| 101 | MP0004924_abnormal_behavior | 0.21790609 |
| 102 | MP0001984_abnormal_olfaction | 0.21523438 |
| 103 | MP0005535_abnormal_body_temperature | 0.21280443 |
| 104 | MP0000249_abnormal_blood_vessel | 0.20235988 |
| 105 | MP0008004_abnormal_stomach_pH | 0.19942001 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.19679440 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.19488718 |
| 108 | MP0009115_abnormal_fat_cell | 0.18269633 |
| 109 | MP0000372_irregular_coat_pigmentation | 0.18119647 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.17912701 |
| 111 | MP0008874_decreased_physiological_sensi | 0.17505740 |
| 112 | MP0005409_darkened_coat_color | 0.17426672 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.16999155 |
| 114 | MP0005503_abnormal_tendon_morphology | 0.16827593 |
| 115 | MP0000579_abnormal_nail_morphology | 0.16192739 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.16138213 |
| 117 | MP0001958_emphysema | 0.14873524 |
| 118 | MP0005332_abnormal_amino_acid | 0.14505431 |
| 119 | MP0001697_abnormal_embryo_size | 0.14421060 |
| 120 | MP0001175_abnormal_lung_morphology | 0.13835431 |
| 121 | MP0003385_abnormal_body_wall | 0.12279779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.40519695 |
| 2 | Nemaline bodies (HP:0003798) | 7.99661703 |
| 3 | Ventricular tachycardia (HP:0004756) | 7.23337829 |
| 4 | Atrial fibrillation (HP:0005110) | 6.46505477 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 6.41665511 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 6.05869443 |
| 7 | Primary atrial arrhythmia (HP:0001692) | 6.03962748 |
| 8 | Supraventricular tachycardia (HP:0004755) | 5.85219596 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.78583763 |
| 10 | Lipoatrophy (HP:0100578) | 5.73664849 |
| 11 | Supraventricular arrhythmia (HP:0005115) | 5.73396736 |
| 12 | Exercise-induced myalgia (HP:0003738) | 5.65118886 |
| 13 | Subaortic stenosis (HP:0001682) | 5.63428635 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.63428635 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 5.32126908 |
| 16 | Muscle fiber splitting (HP:0003555) | 5.04209826 |
| 17 | Syncope (HP:0001279) | 4.96644199 |
| 18 | Right ventricular cardiomyopathy (HP:0011663) | 4.92189412 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 4.78952673 |
| 20 | Dilated cardiomyopathy (HP:0001644) | 4.70249514 |
| 21 | Myoglobinuria (HP:0002913) | 4.66891063 |
| 22 | Palpitations (HP:0001962) | 4.64012670 |
| 23 | Prolonged QT interval (HP:0001657) | 4.62115582 |
| 24 | Bundle branch block (HP:0011710) | 4.47861297 |
| 25 | Ventricular arrhythmia (HP:0004308) | 4.34535644 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 4.25832151 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 4.14440676 |
| 28 | Myopathic facies (HP:0002058) | 3.87907642 |
| 29 | Ventricular fibrillation (HP:0001663) | 3.83644627 |
| 30 | Heart block (HP:0012722) | 3.80441616 |
| 31 | Distal arthrogryposis (HP:0005684) | 3.75361300 |
| 32 | Rhabdomyolysis (HP:0003201) | 3.65298100 |
| 33 | Atrioventricular block (HP:0001678) | 3.64149765 |
| 34 | Abnormal atrioventricular conduction (HP:0005150) | 3.57345944 |
| 35 | Acute necrotizing encephalopathy (HP:0006965) | 3.44677678 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.42536179 |
| 37 | Abnormal EKG (HP:0003115) | 3.32476118 |
| 38 | Increased connective tissue (HP:0009025) | 3.31247685 |
| 39 | Round ear (HP:0100830) | 3.22335125 |
| 40 | Hepatic necrosis (HP:0002605) | 3.22292564 |
| 41 | Left ventricular hypertrophy (HP:0001712) | 3.18604919 |
| 42 | Myotonia (HP:0002486) | 3.04606333 |
| 43 | Ragged-red muscle fibers (HP:0003200) | 2.97423199 |
| 44 | Distal lower limb amyotrophy (HP:0008944) | 2.95974460 |
| 45 | Acute encephalopathy (HP:0006846) | 2.90427184 |
| 46 | Ulnar deviation of the wrist (HP:0003049) | 2.89177033 |
| 47 | Frequent falls (HP:0002359) | 2.88704666 |
| 48 | Palmoplantar keratoderma (HP:0000982) | 2.86268877 |
| 49 | Progressive macrocephaly (HP:0004481) | 2.84472481 |
| 50 | Hepatocellular necrosis (HP:0001404) | 2.81237131 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.77573871 |
| 52 | Difficulty running (HP:0009046) | 2.74817195 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.73189784 |
| 54 | Conjunctival hamartoma (HP:0100780) | 2.69266928 |
| 55 | Increased CSF lactate (HP:0002490) | 2.65119486 |
| 56 | Hypoglycemic coma (HP:0001325) | 2.60913646 |
| 57 | Type 1 muscle fiber predominance (HP:0003803) | 2.59053532 |
| 58 | Ketoacidosis (HP:0001993) | 2.57647190 |
| 59 | Scapular winging (HP:0003691) | 2.55545586 |
| 60 | Cerebral edema (HP:0002181) | 2.55429600 |
| 61 | Exercise intolerance (HP:0003546) | 2.48785469 |
| 62 | Neck muscle weakness (HP:0000467) | 2.47921019 |
| 63 | Calcaneovalgus deformity (HP:0001848) | 2.42798439 |
| 64 | Pheochromocytoma (HP:0002666) | 2.42252621 |
| 65 | Double outlet right ventricle (HP:0001719) | 2.39349716 |
| 66 | Congenital malformation of the right heart (HP:0011723) | 2.39349716 |
| 67 | Progressive muscle weakness (HP:0003323) | 2.39138603 |
| 68 | Increased muscle lipid content (HP:0009058) | 2.35267195 |
| 69 | Areflexia of lower limbs (HP:0002522) | 2.35256086 |
| 70 | Difficulty climbing stairs (HP:0003551) | 2.34349384 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.32764627 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.32764627 |
| 73 | Bulbar palsy (HP:0001283) | 2.32125991 |
| 74 | Neoplasm of the adrenal gland (HP:0100631) | 2.31551040 |
| 75 | Absent phalangeal crease (HP:0006109) | 2.27969782 |
| 76 | Muscle stiffness (HP:0003552) | 2.26488521 |
| 77 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.26029831 |
| 78 | Lactic acidosis (HP:0003128) | 2.23722178 |
| 79 | Lower limb amyotrophy (HP:0007210) | 2.22273030 |
| 80 | Respiratory failure (HP:0002878) | 2.20551376 |
| 81 | Abnormality of the foot musculature (HP:0001436) | 2.19558700 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.18892340 |
| 83 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18643684 |
| 84 | Increased serum pyruvate (HP:0003542) | 2.15196760 |
| 85 | Abnormality of glycolysis (HP:0004366) | 2.15196760 |
| 86 | Muscular dystrophy (HP:0003560) | 2.15114038 |
| 87 | Sudden cardiac death (HP:0001645) | 2.14600829 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13222878 |
| 89 | Deformed tarsal bones (HP:0008119) | 2.12083441 |
| 90 | Congestive heart failure (HP:0001635) | 2.10146235 |
| 91 | Gowers sign (HP:0003391) | 2.09914331 |
| 92 | Hip contracture (HP:0003273) | 2.08532531 |
| 93 | Limb-girdle muscle atrophy (HP:0003797) | 2.07355262 |
| 94 | Rimmed vacuoles (HP:0003805) | 2.07066247 |
| 95 | Hypoplastic left heart (HP:0004383) | 2.05403381 |
| 96 | Proximal amyotrophy (HP:0007126) | 2.05107659 |
| 97 | EMG: neuropathic changes (HP:0003445) | 2.03545080 |
| 98 | Hamartoma of the eye (HP:0010568) | 2.02894727 |
| 99 | Generalized muscle weakness (HP:0003324) | 2.02185035 |
| 100 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02105282 |
| 101 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.01952646 |
| 102 | Weak cry (HP:0001612) | 1.95995907 |
| 103 | Muscle fiber inclusion bodies (HP:0100299) | 1.95513763 |
| 104 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.94643369 |
| 105 | Waddling gait (HP:0002515) | 1.93570623 |
| 106 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93227617 |
| 107 | Foot dorsiflexor weakness (HP:0009027) | 1.92319556 |
| 108 | Neoplasm of head and neck (HP:0012288) | 1.91807422 |
| 109 | Esophageal neoplasm (HP:0100751) | 1.91807422 |
| 110 | Testicular atrophy (HP:0000029) | 1.91152711 |
| 111 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86363505 |
| 112 | Hyperalaninemia (HP:0003348) | 1.85979068 |
| 113 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85979068 |
| 114 | Abnormality of alanine metabolism (HP:0010916) | 1.85979068 |
| 115 | Abnormal finger flexion creases (HP:0006143) | 1.83633261 |
| 116 | Generalized aminoaciduria (HP:0002909) | 1.83473446 |
| 117 | Malignant hyperthermia (HP:0002047) | 1.83363023 |
| 118 | Lipid accumulation in hepatocytes (HP:0006561) | 1.82639557 |
| 119 | Ketosis (HP:0001946) | 1.80651390 |
| 120 | Steppage gait (HP:0003376) | 1.79711299 |
| 121 | Tinnitus (HP:0000360) | 1.76356728 |
| 122 | Spinal rigidity (HP:0003306) | 1.74903300 |
| 123 | Diaphragmatic weakness (HP:0009113) | 1.74577743 |
| 124 | Patent foramen ovale (HP:0001655) | 1.74082403 |
| 125 | Pulmonary artery stenosis (HP:0004415) | 1.72549845 |
| 126 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.72536930 |
| 127 | Abnormality of the tricuspid valve (HP:0001702) | 1.66321788 |
| 128 | Slender build (HP:0001533) | 1.64795147 |
| 129 | Hypoplastic heart (HP:0001961) | 1.61772945 |
| 130 | Fatigable weakness (HP:0003473) | 1.54987616 |
| 131 | Abnormality of the neuromuscular junction (HP:0003398) | 1.54987616 |
| 132 | Hyperkalemia (HP:0002153) | 1.54712543 |
| 133 | Dysmetric saccades (HP:0000641) | 1.50743042 |
| 134 | Limb-girdle muscle weakness (HP:0003325) | 1.48401201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.98047996 |
| 2 | TTN | 5.15568663 |
| 3 | MYLK | 4.83129337 |
| 4 | LMTK2 | 3.59508377 |
| 5 | PKN2 | 3.51030380 |
| 6 | PHKG2 | 3.35710373 |
| 7 | PHKG1 | 3.35710373 |
| 8 | PDK3 | 3.19018360 |
| 9 | PDK4 | 3.19018360 |
| 10 | DMPK | 3.07224863 |
| 11 | STK24 | 2.89458641 |
| 12 | PIK3CA | 2.66218121 |
| 13 | TRIB3 | 2.40474661 |
| 14 | BCKDK | 2.30198603 |
| 15 | NEK1 | 2.28163229 |
| 16 | MUSK | 2.19358872 |
| 17 | TIE1 | 2.09244374 |
| 18 | PIK3CG | 2.04404250 |
| 19 | PDK2 | 1.86369367 |
| 20 | ZAK | 1.73087122 |
| 21 | PINK1 | 1.59109808 |
| 22 | STK38L | 1.56910433 |
| 23 | CDC42BPA | 1.52657008 |
| 24 | ILK | 1.47501125 |
| 25 | PAK3 | 1.43729171 |
| 26 | MARK1 | 1.31088268 |
| 27 | GRK7 | 1.26452805 |
| 28 | CAMK2D | 1.25247439 |
| 29 | PRKD1 | 1.25241893 |
| 30 | STK4 | 1.18508825 |
| 31 | ROCK1 | 1.12274013 |
| 32 | FLT3 | 1.10731387 |
| 33 | DAPK3 | 1.09849929 |
| 34 | TRPM7 | 1.07287658 |
| 35 | WNK4 | 1.03872423 |
| 36 | MAPK12 | 0.91162816 |
| 37 | MAP3K5 | 0.88961940 |
| 38 | MAP3K7 | 0.86916683 |
| 39 | MAP3K6 | 0.83508764 |
| 40 | PRKAA1 | 0.78803844 |
| 41 | MAP2K3 | 0.76896568 |
| 42 | RIPK1 | 0.76325524 |
| 43 | MAP3K3 | 0.74495640 |
| 44 | PKN1 | 0.74350600 |
| 45 | PRKAA2 | 0.73561895 |
| 46 | MAPKAPK3 | 0.73435522 |
| 47 | INSRR | 0.71513895 |
| 48 | EEF2K | 0.69937698 |
| 49 | PTK2B | 0.69415517 |
| 50 | CAMK4 | 0.68981596 |
| 51 | KDR | 0.65464489 |
| 52 | MAP2K4 | 0.64719595 |
| 53 | MAPK4 | 0.63179318 |
| 54 | CAMK1 | 0.62491566 |
| 55 | RPS6KC1 | 0.61984211 |
| 56 | RPS6KL1 | 0.61984211 |
| 57 | STK38 | 0.61888489 |
| 58 | ROCK2 | 0.61210249 |
| 59 | EPHA3 | 0.60368601 |
| 60 | CAMK2A | 0.59330878 |
| 61 | WNK1 | 0.56070086 |
| 62 | PDGFRA | 0.55371380 |
| 63 | CAMK2B | 0.54386868 |
| 64 | PRKD3 | 0.54348424 |
| 65 | RPS6KA6 | 0.52719460 |
| 66 | PRKACB | 0.51733917 |
| 67 | STK39 | 0.48641410 |
| 68 | NME2 | 0.47811620 |
| 69 | DYRK1B | 0.47313536 |
| 70 | LIMK1 | 0.46617991 |
| 71 | MAP2K1 | 0.46179473 |
| 72 | MOS | 0.43569136 |
| 73 | PRKCE | 0.43337000 |
| 74 | TGFBR2 | 0.41688157 |
| 75 | ERBB3 | 0.38994016 |
| 76 | PRKACA | 0.38658427 |
| 77 | KSR2 | 0.38300612 |
| 78 | MAP2K6 | 0.38213402 |
| 79 | CCNB1 | 0.38007448 |
| 80 | AKT2 | 0.37349974 |
| 81 | NEK9 | 0.37098757 |
| 82 | PRKG2 | 0.34845165 |
| 83 | PRKACG | 0.34038156 |
| 84 | CAMK2G | 0.31803362 |
| 85 | ICK | 0.26325850 |
| 86 | PRKCH | 0.24645334 |
| 87 | EPHB2 | 0.24137254 |
| 88 | PDPK1 | 0.23657168 |
| 89 | MAP3K10 | 0.23167775 |
| 90 | MAPK10 | 0.23156931 |
| 91 | PTK6 | 0.22973138 |
| 92 | SGK2 | 0.22683163 |
| 93 | PRKG1 | 0.22563414 |
| 94 | MARK3 | 0.22192974 |
| 95 | PDK1 | 0.22066109 |
| 96 | RPS6KA1 | 0.21966150 |
| 97 | LATS2 | 0.20658460 |
| 98 | LATS1 | 0.18094164 |
| 99 | ZAP70 | 0.17608930 |
| 100 | RPS6KB2 | 0.16962351 |
| 101 | PRPF4B | 0.16059885 |
| 102 | MARK2 | 0.15770322 |
| 103 | EPHB1 | 0.15566532 |
| 104 | NLK | 0.14321438 |
| 105 | STK11 | 0.13619232 |
| 106 | LRRK2 | 0.11961481 |
| 107 | ITK | 0.11960735 |
| 108 | RPS6KA2 | 0.11720379 |
| 109 | MAPKAPK2 | 0.11406084 |
| 110 | TBK1 | 0.11029599 |
| 111 | NME1 | 0.11018483 |
| 112 | MTOR | 0.10974549 |
| 113 | MAP3K13 | 0.10671464 |
| 114 | MAP3K1 | 0.10557250 |
| 115 | SGK3 | 0.10520783 |
| 116 | PAK2 | 0.10359291 |
| 117 | PRKCQ | 0.10327832 |
| 118 | RPS6KA3 | 0.08958383 |
| 119 | FGFR3 | 0.08742866 |
| 120 | SGK223 | 0.08644802 |
| 121 | RET | 0.08421533 |
| 122 | FER | 0.08077313 |
| 123 | UHMK1 | 0.07379030 |
| 124 | SGK1 | 0.07014224 |
| 125 | SIK1 | 0.06587187 |
| 126 | FGFR1 | 0.06507083 |
| 127 | MAPK7 | 0.06267825 |
| 128 | CDK4 | 0.05230387 |
| 129 | MAPK11 | 0.05162065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.13472628 |
| 2 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.77001064 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.26931901 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.79236764 |
| 5 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.75631354 |
| 6 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.69673676 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.67866471 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.05722644 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95025746 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.71890054 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64376253 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.59438948 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 2.45073929 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.44913007 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.35996696 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06625719 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97009194 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81208888 |
| 19 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77232258 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.67248313 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54751288 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51513646 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30918392 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21626366 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19680011 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09101870 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05487691 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00738582 |
| 29 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97384441 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95456907 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94488008 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 0.91342020 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86506198 |
| 34 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83614703 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77546381 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73532062 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73211292 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 0.70326793 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 0.67956939 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67763089 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 0.66971613 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65981187 |
| 43 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64015962 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62684363 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59123655 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58728711 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58497493 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57551456 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56224314 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53690621 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53616446 |
| 52 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52837211 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52258995 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50274812 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 0.45718155 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44689815 |
| 57 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44133975 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 0.39879252 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38914486 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.35100339 |
| 61 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33983711 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32325699 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31658565 |
| 64 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.31035719 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30943710 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30262685 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29654651 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27942739 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27859800 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.27526271 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27117386 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25962400 |
| 73 | Insulin secretion_Homo sapiens_hsa04911 | 0.23801506 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23634952 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23275864 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23045312 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.22485223 |
| 78 | GABAergic synapse_Homo sapiens_hsa04727 | 0.22242195 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.21758900 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.19041537 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18557321 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.18265827 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18037581 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15121698 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.14266924 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.13022815 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.12404750 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.12049103 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.11915661 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.11887892 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08991509 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.07131475 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06923157 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.06508174 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.06366889 |
| 96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.05612392 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.04728244 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.01985999 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.01959035 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.01495324 |
| 101 | Melanogenesis_Homo sapiens_hsa04916 | -0.0606246 |
| 102 | Taste transduction_Homo sapiens_hsa04742 | -0.0561892 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | -0.0561672 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0504722 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0401362 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0389655 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0332987 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | -0.0326055 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0313127 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0300007 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0289181 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0274575 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0174366 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0025486 |
| 115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0013286 |

